Outlook Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $8.1M | $14.9M | $23.4M | $17.4M | $14.5M | $12.5M | $8.0M | $1.7M |
| Accounts Receivable | $1.5M | — | — | — | — | — | — | — |
| Inventory | $3.3M | — | — | — | — | — | — | — |
| Total Current Assets | $17.4M | $27.4M | $31.0M | $27.5M | $21.5M | $17.9M | $13.5M | $3.3M |
| Property, Plant & Equipment | — | — | — | — | $163.6K | $327.2K | $3.2M | $18.5M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $18.6M | $28.8M | $32.3M | $28.5M | $22.8M | $19.7M | $17.1M | $22.3M |
| Liabilities | ||||||||
| Accounts Payable | $10.2M | $8.0M | $6.6M | $3.5M | $2.2M | $2.4M | $2.3M | $3.6M |
| Total Current Liabilities | $45.8M | $42.6M | $46.7M | $19.7M | $6.8M | $15.9M | $20.3M | $32.0M |
| Long-Term Debt | — | — | — | — | — | — | $50.3K | $98.5K |
| Total Liabilities | $50.8M | $101.9M | $46.7M | $19.8M | $18.2M | $16.9M | $27.9M | $43.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-605.7M | $-543.3M | $-467.9M | $-408.9M | $-342.9M | $-289.7M | $-254.5M | $-216.3M |
| Total Stockholders' Equity | $-32.2M | $-73.1M | $-14.4M | $8.7M | $4.6M | $2.8M | $-16.1M | $-25.5M |